These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7872965)

  • 21. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.
    Serreze DV; Leiter EH; Christianson GJ; Greiner D; Roopenian DC
    Diabetes; 1994 Mar; 43(3):505-9. PubMed ID: 8314025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.
    Miyazaki T; Matsuda Y; Toyonaga T; Miyazaki J; Yazaki Y; Yamamura K
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9519-23. PubMed ID: 1409662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
    Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
    Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
    Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice.
    Leiter EH; Serreze DV
    Reg Immunol; 1992; 4(5):263-73. PubMed ID: 1290746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple genes/multiple autoantigens role in type 1 diabetes.
    Abiru N; Eisenbarth GS
    Clin Rev Allergy Immunol; 2000 Feb; 18(1):27-40. PubMed ID: 10907105
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
    Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
    Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.
    Inoue K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Makimo S; Ogihara T
    Diabetologia; 2004 Apr; 47(4):739-47. PubMed ID: 15298352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders.
    Gottlieb PA; Eisenbarth GS
    J Autoimmun; 1996 Apr; 9(2):277-81. PubMed ID: 8738974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of autoimmunity in type I diabetes.
    Faustman D
    J Clin Immunol; 1993 Jan; 13(1):1-7. PubMed ID: 8445041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
    Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
    J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twin studies in insulin dependent diabetes and other autoimmune diseases.
    Rowe RE; Leslie RD
    Diabetes Metab Rev; 1995 Jul; 11(2):121-35. PubMed ID: 7555564
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of major histocompatibility complex class II antigen in NOD mouse thyroid.
    Margolese H; O'Keefe C; Chung F; Ertug F; Wall JR; Bernard NF
    Autoimmunity; 1994; 17(1):1-11. PubMed ID: 8025210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
    Serreze DV; Leiter EH
    Curr Opin Immunol; 1994 Dec; 6(6):900-6. PubMed ID: 7710714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.